[2,4-Difluoro-3-(trifluoromethyl)phenyl]boronic acid, 98%, 1g

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 25g

2-BROMO-3-CHLORO-5-FLUOROPYRIDINE, 95.0%, 25g

(6,6-DIMETHYLMORPHOLIN-2-YL)METHANOL HCL, 95.0%, 1g

a,a-Difluoroacetophenone, 95.0%, 5g

6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine-3-carboxylic acid, 95.0%, 500mg

Tetrakis(4-nitrophenyl)methane, 97%, 100mg

Juego de diapositivas de contraste de fase con objetivos PLPHi IOS de 10x y S40x con corrección de infinito y anillos de contraste de fase para 10x/S40x

benzyl n-{[(5r)-2-oxo-1,3-oxazolidin-5-yl]methyl}carbamate, 97.0%, 250mg

Ethyl 3-(4-(trifluoromethyl)phenyl)-[1,2,4]oxadiazole-5-carboxylate, 95.0%, 1g

Sodium 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate, 72.0%, 100g

1-(2-Cyanoethyl)-1H-indole-6-carboxylic acid, 1g

4-Amino-8-fluoro-2-methylquinoline, 97.0%, 10g